Piper carpunya Ruiz & Pav. (Piperaceae) is a perennial aromatic shrub of Amazonian area of Ecuador and Peru, belonging to the ethnomedicine of these countries. The traditional preparations of the crude drug (fresh leaves used topically as is, and dried leaves in infusions or decoctions) are known for anti-inflammatory, antiulcer, antidiarrheal, antiparasitic effects, and wound healing properties. In light of this traditional evidence, chemical composition (GC-MS) and biological activity, i.e., antioxidant, antifungal (yeast) capacities, and genotoxicity, of Amazonian P. carpunya leaf essential oil (EO) have been investigated in order to valorize some of the putative ethnomedical effects. The EO was obtained through steam distillation of fresh leaves (yield: 7.6 g/kg [0.76%]; refractive index at 20 ∘ C: 1.49; density: 0.928 g/mL). Chemical characterization performed through GC-MS evidenced the presence of 21 compounds (96.2% of the total). The most abundant constituents were piperitone (26.2%), limonene (9.5%), elemicin (7.2%), and -phellandrene (5.6%). In vitro DPPH antioxidant assay showed a weak radical scavenging ability (IC 50 ) if compared to positive control. Low bioactivity of the EO was also demonstrated against yeast, but it showed an interesting synergistic activity (FIC index of EO+fluconazole) against Candida sp. strains. Ames test evidenced the safety of the EO concerning genotoxicity.
Introduction
This study is part of a large research project characterized by the biodiversity mapping of Amazonian Ecuador flora belonging to ethnomedical traditional uses through chemical and biological characterization of EOs [1, 2] .
Since most of the plant species used as traditional health remedies are characterized by flavours and aromatic smell, the study of EOs is one of the best strategies to draw a research profile matching biodiversity and phytomedicine. Piper carpunya Ruiz & Pav (syn. Piper lenticellosum C.D.C.) is a perennial shrub belonging to the Piperaceae botanical family, widely distributed in the Amazonian area of Colombia, Ecuador and Peru. Traditionally, the aromatic Piper species are used in Latin America as analgesics in pain management, toothache and wound treatments [3] . P. carpunya has instead more specific and slightly different ethnomedical applications. In fact, fresh and dried leaves of P. carpunya, mainly known with the vernacular name of "guaviduca," are widely used in traditional preparations (i.e., decoctions or direct application) in tropical and subtropical South American Countries to treat generic inflammations 2 Evidence-Based Complementary and Alternative Medicine (i.e., bronchitis and fever), topical infections (i.e., vaginal candidiasis), gastrointestinal disorders (i.e., ulcers, diarrhea and parasitic intestinal infections) and generic digestive problems [4, 5] .
Not many papers were published about P. carpunya. Some of them deal with the above mentioned uses: for example, the capacity of traditional preparations of P. carpunya to protect in vivo against gastric disorders induced by gastric harmful drugs or Helicobacter pylori infections [4] . Other papers, instead, reported the phytochemical composition of the EO obtained by the leaves of P. carpunya, mainly characterized by terpenes [6] [7] [8] .
Despite the abundant scientific reports about Piper species, the knowledge about P. carpunya EO is still scarce. Therefore, the aim of the present paper is to characterize the EO obtained from the leaves of the Ecuadorian P. carpunya and to evaluate its biological activities. A phytochemical fingerprint was performed through gas chromatography coupled with mass spectrometry (GC-MS) in order to chemically characterize the EO. It was subsequently tested in vitro for antioxidant and antimicrobial evaluations, also through synergistic and time-killing assays, in order to verify the traditional uses assuming that the bioactivities were mainly due to the terpene fraction. For this reason, the most abundant terpene compounds detected in the EO were also tested for the same bioactivities, trying to identify those molecules putatively responsible of the biological properties. Finally, in order to assess the safety of the P. carpunya EO, Ames test with S. typhimurium strains was performed to check possible genotoxic implications.
Materials and Methods

Plant Material and Essential Oil. Piper carpunya
Ruiz & Pav leaves of adult plants from three different stocks were collected in November 2014 at balsamic period (before flowering) from wild shrubs growing in the outskirts of the Kutuku Experimental Station, province of Morona Santiago, Ecuador. After harvesting, the P. carpunya leaves were in situ immediately subjected to hydrodistillation using a portable Clevenger-type apparatus. The EO was extracted by steam distillation (3 h) of P. carpunya fresh leaves (8 kg) using deionized water (8 L). The refractive index was measured at 20 ∘ C using the refractometer Abbe 60, while density was checked using a densitometer DCE-DB 600. The essential oil samples were then stored in amber airtight glass vials at 18±0.5 ∘ C to prevent degradations prior to analyses. A specimen of P. carpunya EO was deposited at Salesian Polytechnic University (Quito, Ecuador) (voucher specimen: HUPS-pi-002). Aliquots of the EO samples were then transferred maintaining the storage conditions of the original specimen to the Department of Life Sciences and Biotechnology, University of Ferrara (Ferrara, Italy) for chemical and biological analyses.
Chemicals.
All solvents and chemicals employed for chemical and biological analyses were chromatographic grade. Solvents, pure compounds, employed as positive reference, were all purchased from Sigma-Aldrich Italy (Milano, Italy; www.sigmaaldrich.com).
Gas Chromatographic Coupled with Mass Spectrometry (GC-MS) and Flame Ionization Detection (GC-FID)
Analyses. P. carpunya EO was analyzed by a Varian GC-3800 gas chromatograph equipped with a Varian MS-4000 mass spectrometer using electron impact and hooked to NIST library. A Varian FactorFour VF-5ms poly-5% phenyl-95%-dimethylsiloxane column (internal diameter, 0.25 mm; length, 30 m; film thickness, 0.15 m) was used. The following conditions were adopted: injector temperature 250 ∘ C, carrier (Helium) flow rate 1 mL/min and split ratio 1:50. Oven temperature was as follows: from 55 to 100 ∘ C at a rate of 1 ∘ C/min, from 100 to 250 ∘ C at a rate of 5 ∘ C/min and then kept constant at 250 ∘ C for 15 min. One microliter of sample dissolved in methanol was injected. For the calculation of the relative retention time (RI), a mixture of C8 to C32 hydrocarbons (Sigma-Aldrich), was previously injected into the system applying the same method used to analyze EO. The constituents of the volatile oil were identified by comparing their GC relative retention times, RI and the MS fragmentation pattern with those of other EOs of known composition, with pure compounds and by matching the MS fragmentation patterns, as well as retention indices, with the above mentioned mass spectra libraries and with those in the literature [12, 13] . The MS conditions were ionization voltage, 70 eV; emission current, 10 Amp; scan rate, 1 scan/s; mass range, 29-400 Da; trap temperature, 150 ∘ C and transfer line temperature, 300 ∘ C. For the quantitative analysis a ThermoQuest GC-Trace gas-chromatograph equipped with a FID detector and the same column above described were used. The operating conditions for gas chromatograph were reported above. FID temperature was 250 ∘ C. The oil percentage composition was performed by the normalization method from the GC peak areas, without using correction factors.
Biological Activities.
Antioxidant properties and antimicrobial activity against different strains of human pathogen yeast Candida albicans were performed using the EO and the most abundant compounds, as putative most responsible agent of biological properties. With specific reference to antimicrobial activities, synergistic interactions were also checked in order to explore the possibility of increasing the biological efficacy employing a formulation with different ratio of EO and fluconazole as synthetic drug commonly used in pharmaceuticals for treating candidiasis. Ames test was finally performed to assess safety of P. carpunya EO for what concerns genotoxicity. All the bioactivities were performed using proper negative and positive controls [14] . All the data reported are the average of three determinations of three independent experiments. [16] . All experiments were assessed in triplicate and values were reported as mean ± SD (standard deviation). 
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Synergy Test.
Synergistic evidence of anti-Candida activity was checked through checkerboard test using EO and fluconazole [18] at the same experimental conditions employed for MIC and MFC determination. Eight serial dilutions (1:2) of P. carpunya and fluconazole were used to build an 8x8 square matrix that allowed to assay 64 different combinations of EO and drug concentration in one 96-well microplate. The X-axis of the matrix corresponded to the EO concentration gradient dilutions (range: 48.8 -6250 g/mL); the Y-axis, instead, was represented by the fluconazole gradient dilutions (range: 0.5 -64 g/mL). The synergistic activity was expressed as fractional inhibitory concentration (FIC index ) and was calculated as follows:
where
The same procedures to detect FIC index for MIC values were performed to check possible synergistic effect for MFC.
Legend: FIC index values ≤ 0.5 means the presence of synergistic effect; 0.5<values≤2 means additive or indifferent effect; values > 2 means antagonistic effect [18] .
Time Killing.
To confirm the synergistic activity, a time-killing fungicide curve was performed [9, 19] . Based on the synergistic results, C. albicans AIDS6 strain was used to test P. carpunya EO and fluconazole combination. AIDS6 strain was grown in tubes filled with Sabouraud dextrose broth (SDB, LTD Oxoid, Basingstoke, Ampshire, England) for 24 h at 28 ∘ C. Then, AIDS6 cultures were centrifuged, washed and resuspended to reach a concentration of 2.5 × 10 5 CFU/mL in RPMI-1640 buffered with MOPS at pH 7.0 and incubated at 28 ∘ C. The following four samples were tested in triplicate: (i) P.carpunya EO (MIC value); (ii) fluconazole (MIC value); (iii) P. carpunya EO and fluconazole in combination (best FIC index concentrations); (iv) P. carpunya EO and fluconazole in combination (the first value higher than the best FIC index concentrations). Tween 20 (0.2%) has been added to increase the solubility of the EO. The same procedure was used to prepare the negative controls (AIDS6 culture and Tween 20, 0.2%). Each sample was incubated at 30 ∘ C and gently shacked (100 rpm). Cell growth was monitored at time 0, after 1h, 2h, 4h, 6h and 24h; 100 L of the AIDS6 culture at each monitoring time was serially diluted (dilution range 1-10 5 ). One hundred microlitres (100 L) of each dilution was seeded in Petri dishes (90 mm diameter) containing SDA and incubated for 48 h at 30 ∘ C in the dark. After incubation, the grown AIDS6 colonies were counted [10] .
Genotoxicity Assay (Ames Test).
To investigate the possible genotoxic activity of P. carpunya EO, Ames test employing the Salmonella typhimurium strains TA97a, TA98, TA100 and TA1535 was performed [11, 20] . An inoculum of each bacterial strain culture (100 L) was added to 20 ml of Nutrient Broth and incubated at 37 ∘ C in an orbital shaker (120 rpm) until a microbial concentration of approximately 2 x 10 8 bacteria/ml is reached. Petri dishes (90 mm diameter) containing a basic agar and low concentrations of histidine and biotin were topped with 2 ml of molten agar (45 ∘ C) prepared with 100 L of fresh bacterial culture and 100 L of EO diluted in DMSO (dilution range: 0.1-10 mg/plate). The mutagenic activity was determined on the basis of the counted colonies of each Salmonella strain in plates treated with different concentrations of P. carpunya EO with metabolic activation [addition of 500 L of S9 mix dissolved in a solution of KCl (33mM), NADPH (4mM), MgCl 2 (8mM), and glucose-6-phosphate (5mM)] or, alternatively, without metabolic activation (500 L of 7.4 pH phosphate buffer). Positive controls were set up with 2 g/plate of 2-aminoanthracene for all Salmonella strains cultured with metabolic activation; and 2 g/plate of 2-nitrofluorene for strains TA97a, TA98, TA1535, and 1 g/plate of sodium azide for TA100 strain, for Ames test performed without activation by S9 mix. Negative controls were set up with 100 L of DMSO, both with and without S9 mix. The plates were incubated for three days at 37 ∘ C and colonies were counted (Colony Counter 560 Suntex, Antibioticos, Italy). All the mutagenic assays were performed in triplicate and the results, integrated by statistical analyses, were considered positive when the number of colonies of revertants was at least double if compared to those of the negative controls [11, 20] .
Statistical Analyses.
All the experiments were performed in triplicate. IC 50 values were assessed by logarithmic regression curves with 95% confident limits. Relative standard deviations and statistical significance (Student's T test; p±0.05) were calculated using software STATISTICA 6.0 (StatSoft Italia srl, Vigonza, Italy).
Results
Chemical Fingerprinting of P. carpunya Essential Oil.
Fresh leaves of P. carpunya were collected during the balsamic period (before flowering) and directly steam-distilled to obtain the essential oil. The distillation yield was of 0.76% (w/w%), the refractive index of 1.49 ± 0.02, and the density of 0.928 ± 0.040 g/mL. The colour was pale yellow, and the smell was persistent and strongly aromatic, similar to that of pepper. GC-MS analyses were performed to determine the chemical characterization of the essential oil: fortytwo (42) compounds (96.2% of the total) were identified. Piperitone (26.2%), limonene (9.5%), elemicin (7.2%), -phellandrene (5.6%), methyleugenol (4.5%), and 1,8-cineole (4.0%) were the most abundant (Table 1) : their experimental mass-spectra were reported in Figure 1. 
Antioxidant Activity of P. carpunya Essential Oil: DPPH
Assay. The DPPH assay was performed to test the antioxidant capacity of P. carpunya EO and of the main compounds detected in the phytocomplex. The results were compared to those achieved with positive control Trolox5 and thymol, taken as reference terpene with well-known antioxidant activity (Table 2 ) [21] .The antioxidant activity of P. carpunya EO was moderately interesting with values very far from both pure compound thymol and Trolox5. Piperitone, limonene, 1,8-cineole, and methyleugenol were tested alone as pure compounds: only the last was active, but the activity of EO could not be explained by these molecules. Their mixture or other minor compounds could be responsible of the DPPH capacity.
Antimicrobial Activity against Candida sp.: Minimum
Inhibitory Concentration. The possible synergistic effects of EO and fluconazole (the first-line agent in the candidiasis treatment) were tested at different doses to evaluate different mutual relations. The fractional inhibitory concentration index (FIC index ) was used as synergy evaluation parameter and was considered synergistic at values less or equal to 0.5 [18] . Table 3 summarizes the results obtained, the activity of the antifungal fluconazole, and the EO tested individually and in combination. The MIC and MFC values for P. carpunya EO were found to be 781 g/mL and 1562 g/mL, respectively, for C. albicans (ATCC 24433); the same results (MIC: 1562 g/mL; MFC: 1562 g/mL) were checked for C. albicans (AIDS6) and C. glabrata (FLU 43976). C. glabrata (FLU 43976) and C. albicans (ATCC 24433) showed the same sensitivity if treated with fluconazole (MIC: 32 g/mL; MFC: 32 g/mL). C. albicans (AIDS6) showed instead that it is more resistant (MIC: 128 g/mL; MFC: 128 g/mL).
Sinergy and Time Killing .
The presence of synergistic effects of a mixture characterized by different concentrations of P. carpunya EO and fluconazole (1:1) was checked on the three Candida sp.strains. The MIC and MFC results that gave the best FIC index data are reported in Table 3 . The MIC and MFC values obtained with EO plus fluconazole solution (EO: 391 g/mL; fluconazole: 4 g/mL) were 4-folds lower than those displayed by the sole EO for both C. albicans (AIDS6) and C. glabrata (FLU 43976). The MIC and MFC obtained with the sole fluconazole were 32-folds higher than those achieved with the mixture of EO and synthetic drug for C. albicans (AIDS6), while they were 8-folds for C. glabrata (FLU 43976) . No synergistic effects were evidenced for C. albicans (ATCC 24433).
The synergistic effect of P. carpunya EO with fluconazole was confirmed by time-kill curve experiments performed employing the C. albicans (AIDS6) strain since it showed the best FIC index . The strain (cell density of 1-5 x 10 5 CFU/mL) was exposed to MIC values of P. carpunya EO, of fluconazole alone and of the EO-fluconazole mixture that displayed the best FIC index (Figure 2) . Time-kill analysis showed that the mixture of P. carpunya EO and fluconazole almost totally inhibited the growth of the Candida strain over 24 hours compared to the negative control. In particular, after only 2 hours of exposure, the microbial growth was almost completely reduced to values similar to those detected after 24 h. 
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Ames Test: Genotoxic Activity.
In order to assess the genotoxic effect of P. carpunya EO, induction or suppression of revertant colonies was examined in Salmonella typhimurium strains. The number of spontaneous revertants of the four strains with or without S9 metabolic activation was determined in each set of experiment and indicated as untreated sample in Table 4 . Different concentrations of the P. carpunya EO did not show any genotoxic effect on Salmonella TA97a, TA98, TA100 and TA1535 strains. Just two doses exhibited mutagenic activity (t/c ≥ 2) against TA1535 and TA97a strain, without metabolic activator (S9 mix) at 500 and 1000 L/plate, respectively. On the other hand, in presence of S9 mix microsomal fraction, the only TA1535 strain evidenced a mutagen sensitivity in presence of the EO both at 500 and 1000 L/plate. In any case, no dose-response trend was observed suggesting the conclusion of the safety of P. carpunya EO with regard to genotoxicity.
Discussion
For the past several years our research group has been involved in studying Amazonian medicinal plants through FICindex: fractional inhibitory concentration index; FIC index ≤ 0.5 means the presence of synergistic effect; 0.5≤FIC index ≤2 means additive or indifferent effect; FIC index > 2 means antagonistic effect [9, 10] . * Values displaying a synergistic effect. * * Concentration in g/mL of EO and FLU, respectively, corresponding to FICindex. MIC: Minimum Inhibitory Concentration ( g/mL); MFC: Minimum Fungicidal Concentration ( g/mL). EO: P. carpunya EO; FLU: fluconazole. Table 4 : Ames test performed to check the genotoxic safety (no. of revertants induced) of P. carpunya EO. The results are expressed as average of number of colonies per plate, followed by the standard deviation (sd). t/c means the ratio between the number of colonies of Salmonella strains grown in presence of EO and those of the negative control (DMSO). If t/c ratio is ≥ 2, following a dose-response trend, the extract can be considered as potential mutagen [11] . their chemical and biological fingerprinting starting from ethnomedical information. These research projects contributed to expanding the knowledge about those plants which are rarely or never studied but which may potentially play a role in improving the efficacy and safety of pharmaceuticals and health products. Moreover, Amazonian plants are particularly interesting since the Amazonian basin is one of the most important biodiversity hotspots, where the ecological conditions and the high density of species per unit area drive the plant secondary metabolism to biosynthetic pathways which are particularly rich in different chemical structures [22, 23] . Therefore, the present research is part of a large project aimed to characterize the Amazonian medicinal flora, with particular reference to aromatic plants which represent the largest part of the sources used in traditional medicinal preparations. Since most of the plant species used as traditional health remedies are characterized by flavour and aromatic smell, the study of EOs is one of the best strategies to draw a research profile matching biodiversity and phytomedicine. For this reason, the chemical fingerprinting is focused on the characterization of EOs, while the biological activities are assayed through in vitro tests to confirm traditional properties or to find new health applications [1, 2] .
Starting from these premises, the purpose of the current research was to study the chemical characterization and biological activities of Amazonian P. carpunya EO.
Chemical Characterization of P. carpunya Essential Oil.
As far as we know, only few papers dealt with the chemical composition of P. carpunya EO. However, comparing our results with those reported for P. carpunya EO from Peru emerged important differences [7] . From a qualitative point of view, every compound detected in the P. carpunya EO from Peru [7] was present in our EO from Amazonian Ecuador, but in smaller quantities. [15, 27, 28] . In general, EOs are largely known as effective antimicrobial agents [13, 29] , but in our study the most interesting evidence is given by the synergistic activity emerged by the combination of P. carpunya EO and fluconazole as synthetic drug. In fact, the possibility to enhance bioactivity of health products combining natural products, such as EOs, and synthetic drugs through synergistic interactions gives the opportunity to reduce the amount of synthetic active compounds, reducing at the same time their adverse effects without limiting the therapeutic efficacy. This kind of results obviously highly valorizes the EO of P. carpunya from Amazonian Ecuador as possible ingredient in modern anti-candidiasis pharmaceuticals, even more if we consider the activity of the synergistic mixture against resistant fluconazole clinical isolated strains and time-killing curve that show the dramatic reduction of microbial growth after just 2 h.
Genotoxic Safety of P. carpunya Essential Oil.
To complement the awareness on the efficacy and the safe possible use of P. carpunya EO, Ames test was carried out [17, 20] . EOs can be used topically or orally administered and the careful examination of possible mutagenic properties is required to confirm and assure the safety of their use [17] . Moreover, some evidence of possible genotoxic activities exerted by EOs is emerging [17] . Traditional uses are by no means warrants of safety since complex set of symptoms and causeeffect relationships are not easily recognized and identified by the population [17, and references therein]. Our results pointed out the safety of the P. carpunya EO with regard to genotoxicity, suggesting also by this aspect the potentiality of its health uses.
Conclusions
The present work provides for the first time phytochemical and biological evidence about P. carpunya EO obtained from fresh leaves collected from plants in the Amazonian Ecuador. The chemical characterization of the EO showed important differences in comparison with other EOs from the same species but from different geographical areas: these results reflect the adapting behaviour of plants to different environments.
The in vitro biological activities suggested, in general, the correct traditional use of the aromatic leaves and their preparations (e.g., topical infections remedy, such as vaginal candidiasis), and their safety under a genotoxic point of view. Particularly promising resulted synergistic activity emerged with aliquots of P. carpunya EO and fluconazole, suggesting interesting opportunities to employ the Amazonian Ecuador EO as ingredient in anti-candidiasis products in which the reduced amount of synthetic drug could lead to the reduction of the possible adverse effects without compromising therapeutic efficacy.
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